Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion description "[When TM expression was compared between the primary and metastatic lesions in the 36 patients who had lymph node metastasis, 14 (39%) showed decreased TM expression, 19 (53%) showed no change, and 3 (8%) showed an increase in the metastatic lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion evidence source_evidence_literature NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion SIO_000772 9234185 NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion wasDerivedFrom befree-20140225 NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion wasGeneratedBy ECO_0000203 NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.